posted on June 22, 2026

L7 Informatics has been recognized by the life sciences industry’s most credible voices for building the execution layer that regulated science runs on. These awards and recognitions span independent analyst firms, growth-ranking programs, executive honors, learning and development award bodies, and regional employer rankings. The common thread across every one of these honors is the same idea L7|ESP was built on: a unified platform that contextualizes data at the point of generation and makes it AI-actionable, rather than a collection of disconnected point solutions.

This page gathers the awards, analyst recognitions, and industry lists L7 Informatics has earned to date, organized by category.

Analyst and Industry Recognition

Independent analyst recognition matters because it is earned through evaluation, not purchased. L7 Informatics has been named, profiled, and cited by both Gartner and Frost & Sullivan across a multi-year span.

Frost & Sullivan

Frost & Sullivan 2025 Frost Radar, Pharmaceutical and Biotech LIMS (2025). Frost & Sullivan named L7 Informatics the top innovator in its 2025 Frost Radar for Pharmaceutical and Biotech Laboratory Information Management Systems. Among 50 global LIMS providers evaluated, L7 achieved the highest Innovation Index score of 4.85 and recorded a Growth Index score of 3.95. Frost & Sullivan cited L7’s unified platform approach, deep workflow orchestration, and ontology-based model that enables AI-actionable data, describing L7 as well positioned to capitalize on AI-driven transformation, global market expansion, and precision medicine.

Gartner

Gartner Hype Cycle and Market Guide Recognition (2020 through 2026). L7 Informatics has been identified as a Sample Vendor and referenced across 34 Gartner Hype Cycle and Market Guide citations from 2020 through 2026, spanning life science manufacturing, research and development, clinical development, commercial operations, discovery research, healthcare providers, and digital care delivery. The complete record follows, organized newest first.

2026

• Gartner, “Hype Cycle for Life Science R&D” Laboratory Informatics Suites, 2026, 22 June 2026
• Gartner, “Hype Cycle for Life Science R&D” Cell and Gene Therapy Platforms, 2026, 22 June 2026
• Gartner, “Hype Cycle for Life Science Manufacturing” Laboratory Information Suites, 2026, ID G00846274, 9 June 2026
• Gartner, “Hype Cycle for Life Science Manufacturing” Cell and Gene Therapy Platform, 2026, ID G00846274, 9 June 2026
• Gartner, “Hype Cycle for Life Science Manufacturing” Hybrid Execution Systems, 2026, ID G00846274, 9 June 2026

2025

• Gartner, “Hype Cycle for Life Science Manufacturing” Hybrid Execution System, 2025, ID G00832373, 16 July 2025
• Gartner, “Hype Cycle for Life Science Manufacturing” Cell and Gene Therapy Platform, 2025, ID G00832373, 16 July 2025
• Gartner, “Hype Cycle for Life Science Manufacturing” Laboratory Informatics Suites, 2025, ID G00832373, 16 July 2025
• Gartner, “Hype Cycle for Life Science R&D” Cell and Gene Therapy Platform, 2025, ID G00832966, 7 July 2025
• Gartner, “Hype Cycle for Life Science R&D” Workbench for Genomics Research, 2025, ID G00832966, 7 July 2025
• Gartner, “Hype Cycle for Life Science R&D” Laboratory Informatics Suites, 2025, ID G00832966, 7 July 2025
• Gartner, Market Guide for Laboratory Information Management Systems, 2025, ID G00757034, Analysts Michael Shanler, Reuben Harwood, Lynn Rice, 16 April 2025
• Gartner, Market Guide for Electronic Laboratory Notebooks, 2025, Analysts Michael Shanler, Reuben Harwood, Lynn Rice, 5 May 2025

2024

• Gartner, “Hype Cycle for Life Science Manufacturing, Quality and Supply Chain”, 2024, ID G00814456, 13 August 2024
• Gartner “Hype Cycle for Life Science Discovery Research”, 2024, ID G00814161, 13 August 2024
• Gartner “Hype Cycle for Life Science Commercial Operations”, 2024, ID G00812983, 13 August 2024

2023

• Gartner, “Hype Cycle for Life Science Clinical Development”, 2023, Analyst Jeff Smith, 20 July 2023
• Gartner, “Hype Cycle for Life Science Commercial Operations”, 2023, Analyst Animesh Gandhi, 19 July 2023
• Gartner, “Hype Cycle for Digital Care Delivery Including Virtual Care”, 2023, Analysts Sharon Hakkennes, Veronica Walk, 16 July 2023
• Gartner, “Hype Cycle for Healthcare Providers”, 2023, Analysts Andrew Meyer, Roger Benn, 16 July 2023
• Gartner, “Life Science CIO’s Strategy for Delivering Cell and Gene Therapy Capabilities”, 2023, Analysts Michael Shanler, Jessica Hong, 20 March 2023

2022

• Gartner, “Hype Cycle for Consumer Engagement and Experience in Healthcare and Life Sciences”, 2022, Analyst Kate McCarthy, 27 July 2022
• Gartner, “Hype Cycle for Life Science Manufacturing, Quality and Supply Chain” 2022, Analysts Michael Shanler, Rick Franzosa, Maria Nieradka, Rohan Sinha, 26 July 2022
• Gartner, “Hype Cycle for Life Science Clinical Development”, 2022, Analysts Jeff Smith, Rohan Sinha, 26 July 2022
• Gartner, “Hype Cycle for Life Science Discovery Research”, 2022, Analysts Michael Shanler, Reuben Harwood, 26 July 2022
• Gartner, “Hype Cycle for Healthcare Providers”, 2022, Analysts Andrew Meyer, Mike Jones, 18 July 2022
• Gartner, “Hype Cycle for Life Science Commercial Operations”, 2022, Analyst Animesh Gandhi, 18 July 2022
• Gartner, “Hype Cycle for Digital Care Delivery Including Virtual Care”, 2022, Analysts Sharon Hakkennes, Veronica Walk, 9 July 2022

2021

• Gartner, “Hype Cycle for Digital Care Delivery Including Virtual Care”, 2021, Analysts Sharon Hakkennes and Mike Jones, 13 July 2021
• Gartner, “Hype Cycle for Healthcare Providers”, 2021, Analysts Mike Jones and Sachin Dev, 12 July 2021

2020

• Gartner, “Hype Cycle for Consumer Engagement With Healthcare and Wellness, 2020, Analysts Mark Gilbert, Jeff Cribbs, 13 August 2020
• Gartner, “Hype Cycle for Life Science Research and Development 2020,” Analysts Jeff Smith, Michael Shanler, 13 August 2020
• Gartner, “Hype Cycle for Life Science Manufacturing, Quality & Supply Chain, 2020, Analysts Michael Shanler, Stephen Meyer, Andrew Stevens, 12 August 2020
• Gartner, “Hype Cycle for Digital Care Delivery Including Telemedicine & Virtual Care, 2020, Analysts Sharon Hakkennes, Laura Craft, Mike Jones, 10 August 2020
• Gartner, “Hype Cycle for Life Science Commercial Operations, 2020, Analysts Animesh Gandhi, Michael Shanler, 6 August 2020
• Gartner, “Hype Cycle for Healthcare Providers, 2020, Analysts Laura Craft, Mike Jones, 5 August 2020

Gartner Cool Vendor in Life Sciences (2020). Gartner recognized L7 Informatics as a Cool Vendor in its Cool Vendors in Life Sciences report, naming L7 as one of only five companies recognized in that report.

Growth and Business Recognition

Deloitte Technology Fast 500 (2021, 2022, 2023, 2024). L7 Informatics ranked on the Deloitte Technology Fast 500 for four consecutive years, one of the longer unbroken runs a private life sciences software company can hold on the list.

The Deloitte Technology Fast 500 ranks the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies, both public and private, in North America. Winners are selected based on percentage fiscal-year revenue growth measured over a three-year period. To qualify, a company must own proprietary intellectual property or technology that is sold in products generating the majority of its operating revenue, hold base-year operating revenue of at least 50,000 US dollars and current-year operating revenue of at least 5 million US dollars, have been in business for at least four years, and be headquartered in North America.

L7’s four appearances:

• 2021. L7 Informatics earned its first place on the Deloitte Technology Fast 500.
• 2022. L7 Informatics returned to the list for a second consecutive year.
• 2023. L7 Informatics made the list for a third consecutive year, in the program’s 29th year, with rankings based on revenue growth from 2019 to 2022. L7 posted revenue growth of 2047 percent over that period.
• 2024. L7 Informatics ranked for a fourth consecutive year, in the program’s 30th year, with rankings based on revenue growth from 2020 to 2023. L7 attributed the sustained growth to rising demand for a unifying platform that breaks down the digital silos created by legacy point solutions and applies process orchestration and data contextualization to enable AI.

Executive Recognition

Marcia Blackmoore, 2025 Top Women Leader in Healthcare Technology. Marcia Blackmoore, Chief Commercial Officer of L7 Informatics, was named a 2025 Top Women Leader in Healthcare Technology, recognized for her work advancing data-first strategies in cell and gene therapy manufacturing and her leadership in the life sciences software market.

Learning and Development Recognition

L7 Informatics has been recognized twice by the Brandon Hall Group HCM Excellence Awards, known across the human capital management field as a benchmark for learning and development excellence.

Brandon Hall Group HCM Excellence Award, Gold (2024). L7 Informatics won the Gold award in the Learning and Development category for Best Training Team at the 2024 Brandon Hall Group HCM Excellence Awards, recognizing the team behind L7’s customer and partner learning programs.

Brandon Hall Group HCM Excellence Award, Silver (2023). L7 Informatics won the Silver award in the Best Customer Training Program category at the 2023 Brandon Hall Group HCM Excellence Awards for its L7|ESP Super User MasterClass, a four-day program built to give customers, partners, and employees deep skills in data and process modeling within the L7|ESP platform.

Workplace and Regional Recognition

Austin Business Journal, Largest Tech Employers (Austin Area). L7 Informatics has been recognized by the Austin Business Journal as one of the largest technology employers in the Austin area, reflecting the company’s growth and its roots in the Austin life sciences and technology community.

About L7 Informatics

L7 Informatics builds the execution layer for regulated science. Its flagship platform, L7|ESP, is a unified digital platform that contextualizes data at the point of generation, orchestrates workflows across research, development, manufacturing, and quality, and provides the operational foundation life sciences organizations need to make AI actionable at scale. L7 serves pharmaceutical companies, biotechs, CRDMOs, diagnostics organizations, cancer centers, CROs, and research institutions at every stage of growth.

—

Gartner does not endorse any vendor, product, or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designations. Gartner research publications consist of the opinions of Gartner’s Research and Advisory organization and should not be construed as statements of fact. Gartner, Hype Cycle, and Frost Radar are trademarks of their respective owners. All product names, logos, and brands are property of their respective owners.